Filing Flows › Accendra Health (ACH) › Q1 2026
Accendra Health (ACH) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 11, 2026
Accendra Health (ACH) reported revenue of $628M for the first quarter 2026 (Q1 2026), -7% from a year earlier and -11% from the quarter before. Operating margin was 2.7%, net loss $6.5M (1.0% of revenue).
Accendra Health, Q1 2026: revenue $628M (-7% year over year), operating margin 2.7%, net loss $6.5M, operating cash flow −$50.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $628M | -11% | -7% |
| Operating profit | $17.1M | -18% | -13% |
| Net earnings | −$6.5M | — | — |
| Operating cash flow | −$50.1M | — | — |
What changed
Revenue was $627.8M in Q1 2026, down 7% year over year and down 11% from the previous quarter. Diabetes was the largest line at 30% of revenue. Sleep therapy lost $14.9M year over year (down 8%), 32% of the total change.
Operating profit was $17.1M, a 2.7% margin (down 0.2 points year over year). The quarter ended with a net loss of $6.5M, narrower than the previous quarter's $56.3M loss. Net interest and other expense of $33.4M was the main reason.
Operating cash flow was −$50.1M. Non-cash charges added back $61.7M of depreciation and amortization and $3.1M of share-based compensation. Working capital and other items used $108.4M. Capital expenditures of $41.6M exceeded it, leaving free cash flow of −$91.7M.
Questions
What was Accendra Health's revenue in the first quarter 2026?
Accendra Health (ACH) reported revenue of $628M for the first quarter 2026 (Q1 2026), -7% from a year earlier and -11% from the quarter before.
Was Accendra Health profitable in the first quarter 2026?
Operating profit was $17.1M (2.7% of revenue) and net loss $6.5M.
Source: Accendra Health 10-Q on SEC EDGAR.